- Home
- FRAF vs LXEO Comparison
FRAF vs LXEO Comparison
Compare FRAF & LXEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FRAF
- LXEO
- Stock Information
- Founded
- FRAF 1906
- LXEO 2017
- Country
- FRAF United States
- LXEO United States
- Employees
- FRAF N/A
- LXEO 72
- Industry
- FRAF Major Banks
- LXEO
- Sector
- FRAF Finance
- LXEO
- Exchange
- FRAF Nasdaq
- LXEO Nasdaq
- Market Cap
- FRAF 165.3M
- LXEO 154.0M
- IPO Year
- FRAF N/A
- LXEO 2023
- Fundamental
- Price
- FRAF $38.81
- LXEO $2.69
- Analyst Decision
- FRAF
- LXEO Strong Buy
- Analyst Count
- FRAF 0
- LXEO 5
- Target Price
- FRAF N/A
- LXEO $22.20
- AVG Volume (30 Days)
- FRAF 17.7K
- LXEO 892.8K
- Earning Date
- FRAF 04-29-2025
- LXEO 05-20-2025
- Dividend Yield
- FRAF 3.35%
- LXEO N/A
- EPS Growth
- FRAF N/A
- LXEO N/A
- EPS
- FRAF 2.63
- LXEO N/A
- Revenue
- FRAF $71,310,000.00
- LXEO N/A
- Revenue This Year
- FRAF N/A
- LXEO N/A
- Revenue Next Year
- FRAF N/A
- LXEO N/A
- P/E Ratio
- FRAF $14.78
- LXEO N/A
- Revenue Growth
- FRAF 5.24
- LXEO N/A
- 52 Week Low
- FRAF $25.90
- LXEO $1.45
- 52 Week High
- FRAF $40.76
- LXEO $19.50
- Technical
- Relative Strength Index (RSI)
- FRAF 62.77
- LXEO 41.96
- Support Level
- FRAF $38.24
- LXEO $2.77
- Resistance Level
- FRAF $39.48
- LXEO $3.35
- Average True Range (ATR)
- FRAF 0.72
- LXEO 0.62
- MACD
- FRAF -0.04
- LXEO -0.09
- Stochastic Oscillator
- FRAF 25.57
- LXEO 0.69
About FRAF Franklin Financial Services Corporation
Franklin Financial Services Corp is a bank holding company based in the United States. It is engaged in general commercial, retail banking and trust services normally associated with community banks. It offers a broad range of banking services to businesses, individuals, and governmental entities which includes accepting and maintaining cheques, savings, and time deposit accounts, providing investment and trust services, making loans and providing safe deposit facilities. The bank also performs personal, corporate, pension and fiduciary services through its Investment and Trust Services Department.
About LXEO Lexeo Therapeutics Inc.
Lexeo Therapeutics Inc is a clinical-stage genetic medicines company committed to transforming healthcare by applying pioneering science to fundamentally alter how diseases are treated. The company focuses on preclinical and clinical stage gene therapies, specifically hereditary and acquired diseases with high unmet needs, which represent its sole business segment.